Ethics, Evidence and Economics in the Pursuit of “Personalized Medicine”

By Lewis Jan   Lipworth Wendy   Kerridge Ian  

Journal of Personalized Medicine, Vol. 4, Iss. 2, 2014-03 ,pp. : 137-146

MDPI

Access to resources Recommend Favorite

Open Access Integrated Therapeutic and Diagnostic Platforms for Personalized Cardiovascular Medicine

By Gladding Patrick A.   Cave Andrew   Zareian Mehran   Smith Kevin   Hussan Jagir   Hunter Peter   Erogbogbo Folarin   Aguilar Zoraida   Martin David S.   Chan Eugene   Homer Margie L.   Shevade Abhijit V.   Kassemi Mohammad   Thomas James D.   Schlegel Todd T.  

Journal of Personalized Medicine, Vol. 3, Iss. 3, 2013-08 ,pp. : 203-237

MDPI

Access to resources Recommend Favorite

Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies

By Bissonnette Luc   Bergeron Michel G.  

Journal of Personalized Medicine, Vol. 2, Iss. 2, 2012-05 ,pp. : 50-70

MDPI

Access to resources Recommend Favorite

Development of a Multiplex and Cost-Effective Genotype Test toward More Personalized Medicine for the Antiplatelet Drug Clopidogrel

By Jeong Hye-Eun   Lee Su-Jun   Cha Eun-Young   Kim Eun-Young   Kim Ho-Sook   Song Young Hwan   Shin Jae-Gook  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-05 ,pp. : 7699-7710

MDPI

Access to resources Recommend Favorite

Personalized Medicine and Cancer

By Verma Mukesh  

Journal of Personalized Medicine, Vol. 2, Iss. 1, 2012-01 ,pp. : 1-14

MDPI

Access to resources Recommend Favorite